Document is current
Any future updates will be listed below
-
Authors
Neufeldt, Christopher J. https://orcid.org/0000-0002-4551-1811
Cerikan, Berati
Cortese, Mirko
Frankish, Jamie
Lee, Ji-Young
Plociennikowska, Agnieszka
Heigwer, Florian https://orcid.org/0000-0002-8230-1485
Prasad, Vibhu https://orcid.org/0000-0001-7450-607X
Joecks, Sebastian
Burkart, Sandy S. https://orcid.org/0000-0003-1096-0550
Zander, David Y. https://orcid.org/0000-0001-9235-6191
Subramanian, Baskaran
Gimi, Rayomand
Padmanabhan, Seetharamaiyer
Iyer, Radhakrishnan
Gendarme, Mathieu
El Debs, Bachir
Halama, Niels https://orcid.org/0000-0003-0344-6027
Merle, Uta
Boutros, Michael
Binder, Marco
Bartenschlager, Ralf https://orcid.org/0000-0001-5601-9307
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (272983813, BI1693/2-1, BI1693/1-2, 240245660, 272983813, TRR 179)
Deutsches Krebsforschungszentrum (fightCOVID@DKFZ)
Helmholtz Association (COVIPA)
Deutsches Zentrum für Infektionsforschung (8029705705)
- License Information
-
More Information
Article History
Received: 2 May 2021
Accepted: 14 December 2021
First Online: 12 January 2022
Competing interests
: R.I. is a shareholder of Spring Bank Pharmaceuticals, Inc. The remaining authors declare no competing interests.
